MAGNESIUM OXIDE- magnesium oxide tablet 
Method Pharmaceuticals, LLC

----------

Magnesium Oxide

Drug Facts

Active ingredient

Magnesium Oxide 400 mg

(241.3 mg Elemental Magnesium)

Purpose

Antacid

Use

relieves: ■ acid indigestion ■ upset stomach

Warnings

Ask a doctor before use if

  • you have kidney disease
  • you are taking a prescription drug (antacids may interact with certain prescription drugs)
  • you are pregnant or breast feeding.

Do not take more than 2 tablets in a 24 hour period.

  • May have a laxative effect.

Keep out of reach of children.

Directions

Other information

Inactive ingredients

Croscarmellose Sodium, Microcrystalline Cellulose, Silicon Dioxide, and Stearic Acid.

Questions?

Call Method at 1-877-250-3427 or FDA at 1-800-FDA-1088

Manufactured for:
Method Pharmaceuticals, LLC
Fort Worth, Texas 76118

Rev. 04/18

Principal Display Panel

NDC 58657-120-12

Magnesium Oxide

400 mg

241.3 Elemental Magnesium

Antacid

120 Tablets

label

MAGNESIUM OXIDE 
magnesium oxide tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58657-120
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM OXIDE400 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize11mm
FlavorImprint Code 120
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58657-120-12120 in 1 BOTTLE; Type 0: Not a Combination Product07/25/2018
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00107/25/2018
Labeler - Method Pharmaceuticals, LLC (060216698)

Revised: 12/2023
Document Id: 0c1d07d4-560b-35b0-e063-6294a90acd99
Set id: 0af63651-f9d9-43b9-b6f0-4878466a82e6
Version: 5
Effective Time: 20231209
 
Method Pharmaceuticals, LLC